News | November 06, 2024
Venus Remedies gets approval from Malaysian PIC/S GMP for pre-filled syringe facility
The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
Revenue at Rs 3,623 crore, EBITDA at Rs 718 crore
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
India has been declared ‘functional’ against all the core regulatory functions of the WHO Global Benchmarking Tool Version VI
We now rank 3rd in pharmaceutical production by volume and 14th by value
Clarity in regulatory frameworks and pathways help in preventing delays in accessing quality-assured, affordable medicines
Mylan and Novo Nordisk reach settlement of US patent litigation related to Ozempic
Emcure will play a crucial role in ensuring the availability of high-quality, low-cost versions of lenacapavir in 120 countries
Cetirizine is used for relief of symptoms of hay fever and other allergic conditions
The product is expected to be launched in Q3FY25
Subscribe To Our Newsletter & Stay Updated
